Robotic spleen‑preserving suprapancreatic and splenic hilar lymph node dissection using the preemptive retropancreatic approach in total gastrectomy for gastric cancer
Updates in Surgery · 2024
DOI: 10.1007/s13304-024-01880-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Updates in Surgery, 2024. Verfasst von Yuma Ebihara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, North 15 West 7, Kita-ku, Sapporo, Hokkaido, 0608638, Japan. y…. Hauptthemen laut MEDLINE: Gastrectomy, Robotic Surgical Procedures, Lymph Node Excision, Stomach Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Advanced gastric cancer that has not invaded the greater curvature is a good indication for total gastrectomy (TG) with spleen-preserving suprapancreatic and splenic hilar lymph node dissection (LND). However, the suprapancreatic and splenic hilar LND increases the area of dissection of the pancreas, and prolonged pressure drainage of the pancreas is required to maintain a clear operative view. This can lead to an increased risk of postoperative pancreatic complications. To report the efficacy of our novel preemptive retropancreatic approach (PRA) for the suprapancreatic and splenic hilar LND in robotic TG (RTG). We report our experience with nine patients with gastric cancer who underwent spleen-preserving splenic hilar LND using PRA during RTG at Hokkaido University from October 2018 to November 2021. The PRA involves initial dissection of the left side of the retropancreatic space, followed by the release of the adherence between the retroperitoneum surface and the pancreas (fusion fascia), which provides a good operative field and prevents contact with the pancreas during the suprapancreatic and splenic hilar LND in RTG. The median operating time was 488 min (254-564 min). The median intraoperative bleeding was 55 mL (0-115 mL). One patient had postoperative complications (above grade II of the Clavien-Dindo classification), but there were no postoperative pancreatic complications. The spleen-preserving suprapancreatic and splenic hilar LND using PRA could help to reduce the postoperative pancreatic complications associated with RTG.Trial registration number and date of registration The Hokkaido University Hospital institutional review board approved the data collection and analysis. The trial registration number and date of registration are No. 021-0022 and July 26, retrospectively registered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, North 15 West 7, Kita-ku, Sapporo, Hokkaido, 0608638, Japan. yuma-ebi@wc4.so-net.ne.jp.
- Division of Minimally Invasive Surgery, Hokkaido University Hospital, North 15 West 7, Kita-ku, Sapporo, Hokkaido, 0608638, Japan. yuma-ebi@wc4.so-net.ne.jp.
- Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, North 15 West 7, Kita-ku, Sapporo, Hokkaido, 0608638, Japan.
Zitieren
APA
Ebihara, Y., Kurashima, Y., Shichinohe, T., & Hirano, S. (2024). Robotic spleen‑preserving suprapancreatic and splenic hilar lymph node dissection using the preemptive retropancreatic approach in total gastrectomy for gastric cancer. Updates in Surgery. https://doi.org/10.1007/s13304-024-01880-w
Vancouver
Ebihara Y, Kurashima Y, Shichinohe T, Hirano S. Robotic spleen‑preserving suprapancreatic and splenic hilar lymph node dissection using the preemptive retropancreatic approach in total gastrectomy for gastric cancer. Updates in Surgery. 2024. doi:10.1007/s13304-024-01880-w
BibTeX
@article{Ebihara2024,
author = {Ebihara, Yuma and Kurashima, Yo and Shichinohe, Toshiaki and Hirano, Satoshi},
title = {Robotic spleen‑preserving suprapancreatic and splenic hilar lymph node dissection using the preemptive retropancreatic approach in total gastrectomy for gastric cancer},
journal = {Updates in Surgery},
year = {2024},
doi = {10.1007/s13304-024-01880-w}
}
EUVIMED